Company / Net Debt per Share
AMICUS THERAPEUTICS, INC. Net Debt per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.60
FY2025
5-year range
$0.50 / $0.87
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#37 of 82
Health Care
What the data says
At $0.60, AMICUS THERAPEUTICS, INC.'s net debt per share ranks #46 of 82 in the Health Care sector. Net Debt per Share has fluctuated over the past 7 years, ranging from $0.03 in FY2019 to $0.87 in FY2020.
Based on SEC 10-K filings.
0.60 in FY2025 with a 5-year CAGR of -7.3%.
Increased from $0.50 to $0.60 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -11.8%
- 5-Year CAGR
- -7.3%
- 10-Year CAGR
- -
Sector benchmark
#46 of 82 in Health CareTop 55% of 82This company $0.60 Sector average $13.70
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 0.5% year-over-year.
- Ranks #37 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2020.
- Lowest net debt per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.60 | -0.5% |
| FY2024 | $0.60 | +19.9% |
| FY2023 | $0.50 | -42.5% |
| FY2022 | $0.87 | +58.5% |
| FY2021 | $0.55 | -37.0% |
| FY2020 | $0.87 | +3048.0% |
| FY2019 | $0.03 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026